ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 33 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q2 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $956,000 | +9.3% | 225,000 | -11.8% | 0.28% | +6.4% |
| Q3 2016 | $875,000 | +101.1% | 255,000 | +64.0% | 0.27% | +43.8% |
| Q2 2016 | $435,000 | -11.8% | 155,500 | +93.2% | 0.18% | -17.4% |
| Q1 2016 | $493,000 | +13.3% | 80,500 | 0.0% | 0.22% | +21.7% |
| Q4 2015 | $435,000 | +39.4% | 80,500 | 0.0% | 0.18% | +3.4% |
| Q3 2015 | $312,000 | -7.4% | 80,500 | 0.0% | 0.18% | +3.5% |
| Q2 2015 | $337,000 | +6.3% | 80,500 | 0.0% | 0.17% | +4.9% |
| Q1 2015 | $317,000 | – | 80,500 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BARD ASSOCIATES INC | 124,300 | $87,000 | 0.04% |
| Hayden Royal, LLC | 16,000 | $12,272,000 | 0.01% |
| Global Strategic Investment Solutions, LLC | 23,000 | $16,000 | 0.01% |
| Founders Capital Management | 8,000 | $6,000 | 0.01% |
| Cable Hill Partners, LLC | 20,000 | $14,000 | 0.00% |
| Jacobi Capital Management LLC | 25,000 | $18,000 | 0.00% |
| Stonebridge Capital Advisors LLC | 22,000 | $15,000 | 0.00% |
| B. Riley Wealth Advisors, Inc. | 37,520 | $27,000 | 0.00% |
| Firestone Capital Management | 5,200 | $4,000 | 0.00% |
| MGO ONE SEVEN LLC | 10,615 | $7,000 | 0.00% |